東嶽集團(00189.HK)預計中期溢利大幅下跌
格隆匯5月14日丨東嶽集團(00189.HK)發佈公告,截至2020年4月30日止4個月的公司擁有人應占淨溢利與2019年4月30日止4個月相比,已大幅減少約60%。董事會預期集團截至2020年6月30日止6個月的公司擁有人應占淨溢利,與2019年6月30日止6個月相比可能會取得大幅下跌。
董事會認為該項減少的主要原因是集團主要產品(包括但不限於製冷劑產品、有機硅產品、PVC、氯礆、二氯甲烷、液礆及其他產品)的平均市價受市況及新型冠狀病毒(COVID-19)疫情影響,與2019年同期相比有所下跌,導致集團於相關期間的收入及毛利率亦有所下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.